Profile of:

Gaëlle Varkas

Full name: Gaëlle Varkas

Current country: Belgium

Membership level: Full

Type of membership: Member

Number of publications: 16

Association of anatomical variants of the sacroiliac joint with bone marrow edema in patients with axial spondyloarthritis (2023)

The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study (2022)

Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis (2021)

High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics (2020)

Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies (2019)

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients (2019)

High Rate of Drug-Free Remission After Induction Therapy With Golimumab in Early Peripheral Spondyloarthritis (2018)

Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis Cohorts (2018)

Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study (2018)

Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study (2017)

ASAS definition for sacroiliitis on MRI in SpA: applicable to children? (2017)

An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series (2017)

MR signal in the sacroiliac joint space in spondyloarthritis: a new sign (2017)

Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis (2017)

Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis (2016)

Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints (2016)